English
Home > Products > tert-Butyl 2,7-diazaspiro[3.5]nonane

China tert-Butyl 2,7-diazaspiro[3.5]nonane Factory

We'll make each individual effort to become exceptional and ideal, and speed up our steps for standing inside the rank of worldwide top-grade and high-tech enterprises for tert-Butyl 2,7-diazaspiro[3.5]nonane,CAS NO 896464-16-7,896464-16-7,diazaspiro[3.5]nonane-7-carboxylate, We warmly welcome friends from all walks of life to cooperate with us.
tert-Butyl 2,7-diazaspiro[3.5]nonane, Our company now has many department, and there have more than 20 employees in our company. We set up sales shop, show room, and product warehouse. In the meantime, we registered our own brand. Now we have tightened inspection for quality of product.

Related Products

Hot Products

  • lumateperone (Tosylate)

    lumateperone (Tosylate)

    Product Name:lumateperone (Tosylate)
    Molecular Formula:C31H36FN3O4S
    Molecular Weight;565.7
    CAS Registry Number;1187020-80-9
  • 2-Aminoethylmethylsulfone hydrochloride

    2-Aminoethylmethylsulfone hydrochloride

    Product Name:2-Aminoethylmethylsulfone hydrochloride
    Molecular Formula:C3H10ClNO2S
    Molecular Weight:159.63
    CAS Registry Number:104458-24-4
  • Ceftriaxone sodium

    Ceftriaxone sodium

    Product Name:Ceftriaxone sodium
    Molecular Formula:C18H19N8NaO7S3
    Molecular Weight;578.57
    CAS Registry Number;74578-69-1
  • Secnidazole

    Secnidazole

    Product Name:Secnidazole
    Molecular Formula:C7H11N3O3
    Molecular Weight;185.18
    CAS Registry Number;3366-95-8
  • Upadacitinib hemihydrate

    Upadacitinib hemihydrate

    Product Name:Upadacitinib hemihydrate
    Molecular Formula:C17H21F3N6O2
    Molecular Weight;398.39
    CAS Registry Number;2050057-56-0
  • (1-methylpiperidin-4-yl)(pyrrolidin-1-yl)methanone

    (1-methylpiperidin-4-yl)(pyrrolidin-1-yl)methanone

    Product Name:(1-methylpiperidin-4-yl)(pyrrolidin-1-yl)methanone
    Molecular Formula:C11H20N2O
    Molecular Weight:196.29
    CAS Registry Number:613678-14-1
  • Related Blog
  • Reviews

  • Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?

    API is fundamental to the modern drug manufacturing process and cutting cost should not be the only criteria that can be applied to the production of an active pharmaceutical ingredient as it can adversely affect human health if the above-mentioned regulations and practices are not followed strictly.

  • Differences Between Pharmaceutical Raw Materials, Excipients and Pharmaceutical Intermediates

    In the pharmaceutical industry, there are various names of raw materials, such as pharmaceutical raw materials, pharmaceutical intermediates and pharmaceutical excipients in the process of pharmaceutical production. This article will take everyone to recognize these three concepts.

  • How is a drug produced?

    ​There are so many different drugs ,with different color /shape ( like capsule ,tablet or Infusion) and price . Here we would like to explain , what makes it so different? How is a drug produced?

  • What are pharmaceutical intermediates?

    Pharmaceutical intermediates are fine chemical products in the production process from pharmaceutical chemical raw materials to bulk drugs or drugs. The synthesis of chemical drugs depends on high-quality pharmaceutical intermediates. This chemical, which does not require a drug production license, can be produced in ordinary chemical plants and can be used in the synthesis of drugs as long as it reaches certain grades.

  • Everything You Need To Know About Active Pharmaceutical Ingredients (API In Pharma)

    Sandoo, as a professional API manufactruer in China, we produces a wide range of active pharmaceutical ingredients which can be used in the production of medicines in different applications.

  • Development Trend of China's Pharmaceutical Intermediate Industry

    The rapid development of China's pharmaceutical intermediate industry is closely related to its national policies. Since 2016, China has issued clear documents to encourage small and medium-sized enterprises to develop new drugs, including chemical raw materials. At the same time, the structural upgrading of the pharmaceutical industry in developed countries has promoted the transfer of global related industrial chains and promoted China's chemical raw material drug supply chain. In addition, the increase in Chinese radiography technology has boosted product demand.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept